Shares of Illumina, Inc. (ILMN) have traded between $263.3 – 380.77. The next earnings date is set for Jan 29, 2020. Let’s see how its prospects are shaping up.

What does Illumina, Inc.(ILMN) do?

Illumina, Inc. develops, manufactures, and markets life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through Core Illumina segment, which serves customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.

ILMN Insider Trading Insight

On 2020-01-06, Tousi Susan H SVP Product Development sold 200 shares of ILMN. That represents a value of $38,465. Not to be outdone, on 2020-01-02, Van Oene Mark S – Sale sold625 shares of ILMN. These insiders are clearly in the know because they work closely with the company.

CRTX Intraday Trading

CRTX is due to report earnings on Feb 11, 2020. In the last year the price has ranged from 19.36 – 72.95. Recently, Epiq Capital Group, LLC purchased 2,800 shares of CRTX. He is a $125,863 shareholder in CRTX.

Looking for stocks similar to ILMN and CRTX?

Here are some stocks to consider: